ALLOANTIGENES MULTIPLEX-PEPTID

European patent · EP3156423 · In force

Register entry

Publication number
EP3156423
Application number
EP15806911
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Jun 11, 2015
Published
Apr 19, 2017
Granted
Feb 19, 2025
Protection ends at the latest
Jun 10, 2035
Next annual fee due
Jun 30, 2027
IPC classes
C07K 17/02 (2006.01)
A61K 39/00 (2006.01)
A61K 39/39 (2006.01)
A61P 19/00 (2006.01)
A61P 25/00 (2006.01)
A61P 27/02 (2006.01)
A61P 35/00 (2006.01)
A61P 37/00 (2006.01)
C07K 16/42 (2006.01)
C07K 7/08 (2006.01)
Priority
JP 2014120999 11.06.2014
PCT application
PCT/JP2015/066865 11.06.2015
PCT publication
WO2015/190555 17.12.2015
Filing language
Japanese
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jul 1, 2026

    Next annual fee due on

    Next annual fee due on
    30.06.2026 → 30.06.2027

    Published in Swissreg on 01.07.2026

  2. Dec 31, 2025

    Change

    Published in Swissreg on 31.12.2025

  3. Jul 1, 2025

    Next annual fee due on

    Next annual fee due on
    30.06.2025 → 30.06.2026

    Published in Swissreg on 01.07.2025

  4. Feb 19, 2025

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 19.02.2025

  5. Feb 19, 2025

    Agent entered

    Representative
    Isler & Pedrazzini AG, Postfach, 8027 Zürich

    Published in Swissreg on 19.02.2025

Parties

Inventor

MASUDA, Kenichi

Sagamihara-shi, Kanagawa 252-0131, JP

ISHII, Yasuyuki

Wako-shi, Saitama 351-0198, JP

TSUKUI, Toshihiro

Koriyama-shi, Fukushima 963-0196, JP

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.